𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tyrosine kinase inhibitors in acute and chronic leukemias

✍ Scribed by Ohanian, Maro; Cortes, Jorge; Kantarjian, Hagop; Jabbour, Elias

Book ID
111981999
Publisher
Informa plc
Year
2012
Tongue
English
Weight
298 KB
Volume
13
Category
Article
ISSN
1465-6566

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prior treatment with the tyrosine kinase
Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia
✍ Shimoni, A; Leiba, M; Schleuning, M; Martineau, G; Renaud, M; Koren-Michowitz, M πŸ“‚ Article πŸ“… 2008 πŸ› Nature Publishing Group 🌐 English βš– 103 KB
Intolerance to tyrosine kinase inhibitor
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia : Definitions and clinical implications
✍ Javier Pinilla-Ibarz; Jorge Cortes; Michael J. Mauro πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract Tyrosine kinase inhibitor (TKI) treatment targeting breakpoint cluster region‐Abelson murine leukemia virus, the cause of chronic myeloid leukemia (CML), has revolutionized therapy for patients with this disease. The majority of patients with CML maintain favorable responses with long‐t